citrulline has been researched along with Ischemic Attack, Transient in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, K; Matsuo, K; Yabuki, Y | 1 |
| Fukunaga, K; Kumagai, K; Morita, M; Shigano, M; Shioda, N; Yabuki, Y; Yamamoto, Y | 1 |
| Bhardwaj, A; Goyagi, T; Hurn, PD; Kirsch, JR; Koehler, RC; Toung, TJ; Traystman, RJ | 1 |
| Makino, T; Miyauchi, T; Muto, A; Nabata, H; Nagafuji, T; Sugiyama, M | 1 |
| Belmonte, A; del Pilar Fernandez Rodriguez, M; Garcia-Iglesias, E; Garcia-Novio, M; Meizoso, MJ | 1 |
| Quast, MJ; Wei, J | 1 |
| Eliasson, MJ; Ferrante, RJ; Huang, Z; Molliver, ME; Moskowitz, MA; Sasamata, M; Snyder, SH | 1 |
7 other study(ies) available for citrulline and Ischemic Attack, Transient
| Article | Year |
|---|---|
Combined l-citrulline and glutathione administration prevents neuronal cell death following transient brain ischemia.
Topics: Animals; Apoptosis; Brain Ischemia; CA1 Region, Hippocampal; Cell Death; Citrulline; Disease Models, Animal; Glutathione; Hippocampus; Ischemia; Ischemic Attack, Transient; Male; Memory Disorders; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type III | 2017 |
Oral L-citrulline administration improves memory deficits following transient brain ischemia through cerebrovascular protection.
Topics: Administration, Oral; Animals; Cell Death; Cerebrovascular Circulation; Citrulline; Disease Models, Animal; Immunohistochemistry; Ischemic Attack, Transient; Male; Memory; Memory Disorders; Mice; Mice, Inbred C57BL; Microdialysis; Neurons; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type III | 2013 |
Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats.
Topics: Animals; Arginine; Cerebral Infarction; Citrulline; Corpus Striatum; Disease Models, Animal; Ischemic Attack, Transient; Male; Microdialysis; Neuroprotective Agents; Nitric Oxide; Piperidines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid, kappa; Treatment Outcome | 2003 |
The neuroprotective effect of a potent and selective inhibitor of type I NOS (L-MIN) in a rat model of focal cerebral ischaemia.
Topics: Analysis of Variance; Animals; Arterial Occlusive Diseases; Cerebral Arteries; Citrulline; Disease Models, Animal; Enzyme Inhibitors; Evaluation Studies as Topic; Ischemic Attack, Transient; Isoenzymes; Male; Neuroprotective Agents; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Thiourea | 1995 |
Effect of tirilazad on brain nitric oxide synthase activity during cerebral ischemia in rats.
Topics: Animals; Arginine; Brain; Citrulline; Enzyme Inhibitors; Ischemic Attack, Transient; Kinetics; Male; Neuroprotective Agents; Nitric Oxide Synthase; Pregnatrienes; Rats; Rats, Wistar | 1997 |
Effect of nitric oxide synthase inhibitor on a hyperglycemic rat model of reversible focal ischemia: detection of excitatory amino acids release and hydroxyl radical formation.
Topics: Animals; Cell Survival; Citrulline; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Inhibitors; Glutamic Acid; Hydroxyl Radical; Hyperglycemia; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 1998 |
Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage.
Topics: Animals; Brain; Cerebral Infarction; Citrulline; Corpus Striatum; Enzyme Activation; Functional Laterality; Immunohistochemistry; Injections, Intraperitoneal; Ischemic Attack, Transient; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Microinjections; N-Methylaspartate; Neurons; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Oxidants; Tyrosine | 1999 |